This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Real validated MPC1 Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-MPC1 WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~12.3 kDa | |
| Gel | 15% (standard starting point) | |
| Positive control | Appendix (IHC candidate; verify WB) +4 more | |
| Negative control | Suggested KO / knockdown lysate |
| PTM | Acetylated | |
| Caveat | Peptide-blocking control | |
| Gene-set association | MSigDB Hallmark membership | |
| Isoform | 1 isoform(s) |
The A30578 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.
| Sample / lysate | various cells (catalog A30578) |
| Gel % | 15% (standard starting point) |
| Load | 20–30 µg total protein per lane; optimize for abundance (standard starting point) |
| Transfer | Short semi-dry transfer; verify retention (standard starting point) |
| Membrane | 0.2 µm PVDF (standard starting point) |
| Blocking | 5% milk or 5% BSA in TBST (standard starting point) |
| Primary antibody | A30578; use the WB datasheet starting dilution (standard starting point) |
| Primary incubation | Overnight at 4 °C (standard starting point) |
| Secondary antibody | Species-matched HRP conjugate at validated dilution (standard starting point) |
| Secondary incubation | 1 h at room temperature (standard starting point) |
| Wash | 3 × 5 min in TBST (standard starting point) |
| Detection | ECL; bracket exposures to avoid saturation (standard starting point) |
MPC1 has a predicted monomer mass of 12.3 kDa; dimerization could affect migration, but no empirical band or demonstrated shift is supplied.
| Band near 12.3 kDa | consistent with the predicted MPC1 monomer size; confirm identity with an antibody control |
| Band near 25 kDa | could reflect a retained MPC1 homodimer; dimer formation and migration are unverified |
| Higher band of uncertain size | could reflect retained MPC1–MPC2 association; band identity requires confirmation |
| Weak band in a soluble fraction | MPC1 resides in the mitochondrial inner membrane and may be poorly recovered |
| Predicted MPC1 monomer mass | sets a 12.3 kDa sequence-based reference, not a measured migration |
| 109-residue MPC1 sequence | underlies the predicted monomer mass; no cleavage is listed |
| Possible MPC1 homodimer | could produce a band near twice the monomer mass if it remains intact during electrophoresis |
| MPC1–MPC2 heterodimer | could migrate above the MPC1 monomer if retained; its apparent mass is not supplied |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | MPC1 is an inner-membrane protein that may be poorly extracted | check mitochondrial membrane recovery and compare an enriched fraction |
| Band higher than expected | a retained MPC1 dimer is possible | compare reducing and denaturing conditions and verify band identity |
| Band lower than expected | band identity or sample integrity is uncertain | check sample integrity and use an antibody specificity control |
| Multiple bands | retained complexes or antibody cross-reactivity are possible | compare denaturing conditions and use a peptide-block or independent antibody control |
| Weak or no signal | poor recovery of the inner-membrane protein is possible | check membrane extraction, loading, and a positive sample |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Appendix | glandular cells | High | Protein (IHC) | HPA → |
| Bronchus | respiratory epithelial cells | High | Protein (IHC) | HPA → |
| Cerebellum | cells in granular layer | High | Protein (IHC) | HPA → |
| Colon | glandular cells | High | Protein (IHC) | HPA → |
| Duodenum | glandular cells | High | Protein (IHC) | HPA → |
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Adipose tissue | adipocytes | Low | Protein (IHC) | HPA → |
| Bone marrow | hematopoietic cells | Low | Protein (IHC) | HPA → |
| Lymph node | non-germinal center cells | Low | Protein (IHC) | HPA → |
| Oral mucosa | squamous epithelial cells | Low | Protein (IHC) | HPA → |
| Ovary | ovarian stroma cells | Low | Protein (IHC) | HPA → |
Deeper troubleshooting and optimisation questions for MPC1, answered from its protein features.
Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.
the supplier A30578 (Anti-BRP44L) is listed for MPC1 with reported human, mouse, and rat reactivity and a Western blot image described as using various cells. The supplied evidence does not establish independent validation.
Which to pick: A30578 is the only listed option. Check its reported reactivity against your sample species; its WB image offers an example, though the supplied caption does not identify the individual cell samples or conditions.